Innovation Ventures



Barry Selick, PhD

Vice Chancellor, Business Development, Innovation and Partnerships
Innovation Ventures

Prior to joining UCSF, Barry was the CEO of Threshold Pharmaceuticals, a fully integrated oncology drug discovery/clinical development company that he led as CEO from its Series A financing through IPO to its eventual sale in 2017. He was also a Venture Partner at Sofinnova Ventures from June 2002 until July 2007. Prior to Threshold, Barry co-founded and was CEO and Chairman of Camitro, a venture capital backed drug discovery technology company with teams in California and Cambridge, UK, which was acquired 2 years after its founding. Before Camitro, Barry was at Affymax Research Institute, which was acquired by Glaxo Wellcome, plc as its drug discovery technology development center and where Barry was Vice President of Research, responsible for technology development and drug discovery. Prior to Affymax, Barry was at Protein Design Labs (PDL) and Anergen. As a bench scientist at PDL, he co-invented the technology underlying fully humanized antibody therapeutics and applied that to daclizumab (Zenapax), the first FDA-approved fully humanized antibody therapeutic, that was licensed to and commercialized by Roche for the prevention of kidney transplant rejection. This technology has contributed to more than 15 FDA approved therapeutics with cumulative revenues in excess of $200B. Throughout his career, Barry has been a member of the Boards of Directors of a dozen both early stage venture capital-backed as well as public biotech companies and Chairman and/or Lead Director of 9 of those.

With a BA in Biophysics and PhD in Biology from the University of Pennsylvania, Barry was a Damon Runyan-Walter Winchell Cancer Fund Fellow as well as a Senior Fellow of the American Cancer Society at UCSF.

Peter Kotsonis, PhD

Executive Director
Office of Strategic Alliances

Peter is PhD-neuroscientist and drug hunter with 14 years in the pharmaceutical industry, project leader and co-inventor of Ronopterin (VAS203) for traumatic brain injury currently in Phase III clinical development. Peter has experience in academic start-ups (VasoPharm Biotech GmbH) and pharma settings (Novartis Ag and Dainippon Sumitomo Pharma Co, Ltd). He joined UCSF in 2013, and his responsibilities include driving new partner opportunities, developing novel partnering models, and programmatic support using alliance management “best practices” comparable to industry. 

Charles Hart, PhD

Director
Catalyst

Charles Hart is the director of the Catalyst program. From 2004 to 2017 he was at Threshold Pharmaceuticals and responsible for both in vitro and in vivo preclinical translational studies. He was also project leader for the global clinical development program for the hypoxia-targeted anticancer drug evofosfamide (TH-302), a partnership with Merck KGaA. Prior to joining Threshold, Charles was Senior Director of Biology at Galileo Pharmaceuticals (2001 to 2004), Director of Drug Discovery at Signature Bioscience (2000 to 2001), and a Research Unit Director at Affymax (1990 to 2000). Charles received his AB in cell biology from the University of California, Berkeley in 1977, an MS in developmental biology from Stanford University in 1980, a PhD in molecular biology and genetics from Yale University in 1987, and completed a postdoctoral fellowship at the University of Strasbourg, France in 1990.

Michael Lesh, MD

Executive Director, Health Technology Innovation
Catalyst

Michael D. Lesh, MD is a physician, scientist and entrepreneur. He earned undergraduate and graduate degrees in Computer Science and Bioengineering from the Massachusetts Institute of Technology (MIT) before entering medical school at the University of California San Francisco (UCSF).

He is currently Executive Director of Health Technology Innovation in the Office of the Vice Chancellor for Business Development, Innovation and Partnership at UCSF whose mission is to commercialize the University's research and inventions. Dr. Lesh focuses on high value digital health and medical device opportunities, mentors entrepreneurs and start-ups, and has ultimate responsibility for the Catalyst program, UCSF’s translational accelerator.

After completing Internal Medicine training at UCSF and Cardiology and Cardiac Electrophysiology at the Hospital of the University of Pennsylvania, he joined the faculty at UCSF, where he was Chief of Cardiac Electrophysiology. Dr. Lesh's research spanned a wide range from bench to bedside. He pioneered a number of procedures for catheter ablation of cardiac arrhythmias, and is the author of over 300 scientific papers, book chapters and books. Dr. Lesh holds over 200 patents issued or pending, including the fundamental method for pulmonary vein isolation (PVI) for atrial fibrillation, and left atrial appendage occlusion (LAAO) to prevent stroke.

Since 1997, Dr. Lesh has founded a number of medical device companies based on his inventions. Johnson and Johnson (JNJ) acquired his first venture, Atrionix, developer of a novel ultrasound ablation catheter for PVI in AF.

Dr. Lesh founded and was Chairman and CEO of Mitralife, which developed a catheter-based treatment for mitral valve disease and CHF; and Appriva, which developed PLAATO, a percutaneous trans-catheter device for preventing stroke. Mitralife and Appriva were acquired by ev3, Inc. and subsequently Medtronic. He was the founder and CEO of Evera Medical, which developed novel implants for plastic and reconstructive surgery.

Dr. Lesh was founder, Chairman and CEO of Middle Peak Medical (acquired by Symetis SA), which is developing a percutaneous implant to replace surgery for mitral regurgitation.

He is, or has been, on the Board of Directors of HeartScape Technologies (acquired by Roper), Stentys (IPO as STNT), Abate, Inc. (break-through biologic for atopic dermatitis), Sira Medical (futuristic augmented reality for surgical planing), and Cordance Medical (open BBB for treatment of brain disease). Dr. Lesh serves as a mentor to numerous entrepreneurs and participates as an “angel" investor in early stage companies across the healthcare space.

Anthony Francis

Executive Director
Office of Technology Management

Anthony joins Innovation Ventures to lead the Office of Technology Management after an extensive career in technology management and transfer in Australia, most recently as the managing director of GP Partners, a group investing in primary care innovations made through their own accelerator team. Before that, Francis established Flinders Partners at Flinders University where he became managing director of that organization and led it to establish 12 spin off companies, with numerous licenses and many commercial partnerships. He also founded TCG, a specialist technology commercialization company that was acquired by Deloitte.

Anthony has spent the last 25 years deeply engaged with researchers, commercial partners and investors, often creating new ways to achieve success. Because it is often administrative issues that slow innovation and frustrate inventors and partners alike, Anthony excels at cutting through “red tape” and confusion about business models by intervening personally to find solutions that benefit all stakeholders.

“In the coming year Innovation Ventures will be even more proactive,” Anthony Francis says. “The best way to bridge our researchers to their potential markets is to partner even more closely with both our UCSF peers and our external collaborators. We need to make it as easy as possible to access UCSF innovations.”

Being a trusted partner to our investigators is the key objective of UCSF Innovation Ventures. With Anthony’s leadership we believe that our faculty will discover more opportunities for growth, as their research extends to its full potential. He is a boon to our team, bringing with him a wealth of industry knowledge, experience, and relationships. We trust him to guide our technology management forward as we continue to develop healthcare science and bring these discoveries to the people who need them most.   

“It is a privilege to work among such great science and healthcare professionals,” Anthony says. “We hope to build even stronger partnerships with our UCSF researchers and bring the best innovation to the benefit of all.”

Todd Pazdera, PhD

Senior Associate Director, Engagement & Opportunity Development
Office of Technology Management

I have over 10 years in licensing and business development experience that includes building significant research collaboration and licensing partnerships between academia and the life sciences industry. I also have significant interest and experience in starting venture backed companies based on university technology.

I did my Ph.D. in Biological Sciences at Carnegie Mellon University in the lab of Jon Minden, studying the role of programmed cell death in Drosophila embryonic development. I also have a B.S. in Cell and Structural biology (with honors) from the University of Illinois where I did neuroscience research.

My roles include faculty engagement to learn about the commercial relevance of their research and to educate them on what makes a "good invention", evaluating market opportunities to facilitate UCSF based start-ups, and building new relationships with industry and early stage investors. My focus areas include diagnostic, therapeutic, digital health and medical device technologies.

Engagement & Opportunity Development

Stephanie Marrus, MBA, MA

Director
Entrepreneurship Center

Stephanie Marrus is Director of the Entrepreneurship Center. Her mission is to help start companies from UCSF science and technology and to build the entrepreneurial ecosystem at the University. Since joining in 2012, she has developed a robust suite of programs that have contributed to a vibrant entrepreneurial community at UCSF. In addition to heading the Center, she teaches and mentors startups and is Senior Lecturer/Course Director for UCSF’s entrepreneurship classes.

During a 25-year plus business career, she has worked with over 1000 companies in science and technology based industries as member of the management team, business consultant or mentor. Many of these companies have their technological roots at Berkeley, Stanford, UCSF, MIT and Harvard. She has had roles as CEO, COO and VP Business Development for public and private venture capital backed companies, led partnering and M&A transactions, headed corporate development, strategy, marketing, communications and investor relations. Her sector experience is in information technology and life sciences/healthcare.

In addition to her business career, she served as Deputy Secretary of Economic Affairs for Massachusetts governor William F. Weld, leading economic development and business policy, She also chaired an environmental cleanup fund board and became the fund’s Executive Director. She was President of a medical research foundation and served on the Advisory Board of a social venture startup accelerator. She mentors entrepreneurs globally through the US State Department and other programs.

She has translated her business experience to the classroom and teaches experiential courses in entrepreneurship in Silicon Valley and globally. She has been affiliated with entrepreneurship programs at the University of California, Berkeley and Stanford University’s Technology Ventures Program. She has taught and presented at conferences in Europe, Latin America, the Middle East, Africa and Asia. She frequently presents to international groups at UCSF.

Her academic titles have included Senior Lecturer at UCSF, Adjunct Professor at UC Berkeley’s Center for Entrepreneurship in Technology, Entrepreneur-in-Residence at UC Berkeley’s Haas School of Business and Entrepreneur–in-Residence for the Global Entrepreneurial Marketing Course at Stanford, She is National Science Foundation Certified National Faculty for Innovation Corps (I-Corps), its highly successful training for entrepreneurs. She led the creation of Lean LaunchPad for life science/healthcare under an NSF grant, now taught nationally by the NIH. She has been a guest lecturer at Singularity University.

Her global titles have included Adjunct Professor, St. Petersburg State University Graduate School of Management, Russia; Entrepreneur-in-Residence, King Abdullah University of Science and Technology (KAUST), Jeddah, Saudi Arabia; faculty at the Moscow School of Management Skolkovo Startup Academy in Russia and in Silicon Valley. She attended the US Russia Bilateral Presidential Commission meeting on innovation in Moscow. She has been a guest speaker in Saudi Arabia under the sponsorship of Princess Sitah Bint Abdullah Al-Saud, daughter of King Abdullah; the US Consulate General and the Jeddah Chamber of Commerce, and taught at King Abdullah University of Science and Technology (KAUST). She has taught at Tsinghua University, Beijing, at ESADE Business School Barcelona in Argentina Chile Mexico Vietnam and Morocco. She taught for the Finnish Ministry of Foreign Affairs and the Vietnam Ministry of Science and Technology in Vietnam, presented to local and US officials at the US Embassy in Hanoi and keynoted the Peace through Entrepreneurship conference in Morocco.

She participates in the State Department’s International Speaker Program and led a panel at the Global Entrepreneurship Summit (GES 2016) in Silicon Valley.

Her views on entrepreneurship in emerging markets have been published in the Wall Street Journal, the Moscow News and AmericaEconomia. She has been interviewed by Russian television, the BBC and Argentine radio.

Marlene Grenon, MD

Director of Digital Health and AI
Innovation Ventures

Dr. Marlene Grenon is a practicing physician, scientist and entrepreneur. She currently holds the role of Director of Digital Health at UCSF Innovation Ventures and Associate Clinical Professor in the Department of Surgery at UCSF, where she practices vascular medicine. Dr. Grenon has served as the Chief Medical Officer of Evry Health, as a vascular surgeon at the VAMC San Francisco and has an Adjunct Faculty at the International Space University. She has published over 70 peer-reviewed publications. She has more than 20 years of experience in the health care industry and has been the lead investigator for clinical trials funded by the NIH and NASA/NSBRI.

Dr. Grenon holds an MD from McGill University, a MMSc from Harvard Medical School, an MBA from Brown University and IE Business School, and a diploma in Space Sciences from the International Space University. She completed a residency in cardiac surgery (McGill) and fellowships in vascular surgery (University of British Columbia), endovascular surgery (Arizona Heart Institute) and aerospace medicine research (Harvard/MIT).  She has also held roles in the aerospace medicine community including with NASA and the FAA. She is a diplomate of the American Board of Vascular Medicine, a fellow from the Royal College of Physicians and Surgeons of Canada (RCPSC) with Certificate of Specialist in both cardiac and vascular surgery. She advises start-ups in the Bay Area with a focus on digital health and serves as an expert consultant to the American Medical Association on matters of digital health and AI.

Elizabeth Edmiston, PhD

Alliance and Business Development Manager
Office of Strategic Alliances

Beth joined the Office of Strategic Alliances as an Alliances and Business Development Manager in October 2018. Previously, Beth worked in market research consulting where she informed pre-launch strategies for global biopharmaceutical companies. She received her Ph.D. in Immunology from UC Davis, where she studied the maternal immune system and its effects on neurodevelopment, specifically she was working to elucidate the role of maternal autoantibodies in autism spectrum disorders.

Cammie Edwards, PhD

Associate Director
Office of Strategic Alliances

Cammie Edwards, PhD, Program and Alliance Management (ITA), provides a direct interface between UCSF teams and external collaboration partners. In that role, she works with both teams in establishing collaborative strategic plans, maintaining effective communication, promoting cross-functional activities, monitoring progress and developing risk mitigation strategies. Cammie joined UCSF as the Program Director for the Stephen and Nancy Grand Multiple Myeloma Translational Initiative (Grand MMTI) in 2011, where she provides strategic and operational oversight for the program. Prior to joining the Grand MMTI, Cammie worked for 10 years with DNA Bridges, Inc., a corporate development firm dedicated to helping life science companies advance their programs and products. In her role there, she assisted clients in raising funds (> $20 million in both private and federal funding), corporate positioning, business development and managing large contracts for clients. She worked successfully with both U.S. and international clients in a broad range of areas including cancer therapeutics, biologics, vaccines, biodefense and biomarker technologies. Dr. Edwards obtained her PhD from the University of California, Berkeley.

Sean Karlin

Brand & Visual Communications Manager
Office of Strategic Alliances

With an education in film, a passion for adventure, and the good fortune to work with organizations like Greenpeace, Amazon Watch and Sea Shepherd, Sean has spent much of his life travelling and documenting the environmental movement. In 2005 he settled in San Francisco, joined Beyond Pix Studios to cover the world’s biggest technology innovators, including Apple, LinkedIn and Amazon. Along with new priorities came new skills that included commercial production and design.

Working with an incredible team of creative professionals, Sean led commercial campaigns for local and national broadcast television, which was honored with a pair of Emmy Awards for directing ad campaigns in 2009 and 2014.

In 2016, he began working with the University of California designing and producing educational media projects, and today you can find him wandering the ivy walled campus of UC San Francisco tending to brand and visual communications with the Innovation Ventures team.

Yuxi Lin, PhD

Alliance and Business Development Manager
Office of Strategic Alliances

Yuxi is an Alliances and Business Development Manager at the Office of Strategic Alliances, where she works on developing industry partnerships, research scouting, and business development at UCSF. Previously, Yuxi worked as an intern at Columbia University's tech transfer office, Columbia Technology Ventures. She received her Ph.D. in biomedical sciences from Columbia University focusing on metabolic disorders and did her postdoctoral research in neurobiology and gastroenterology at UCSF.

Olivia Sims, PhD

Alliance and Business Development Manager
Office of Strategic Alliances

Olivia joined the Office of Strategic Alliances in November 2018 as an Alliances and Business Development Manager. Previously, Olivia worked as a scientific advisor where she focused on protection of biotechnology intellectual property. Olivia received her PhD in Immunology from Mayo Clinic School of Biomedical Sciences where she studied the endogenous antiviral mechanisms in the domestic cat. Subsequently, Olivia was awarded an NIH institutional research and academic career development award to pursue her postdoctoral studies at UCSF in the laboratory of Dr. Melanie Ott. A focus of her postdoctoral research was to identify the molecular mechanisms contributing to transcriptional repression at the HIV-2 promoter. During her tenure as a UCSF postdoctoral fellow, she also worked as an immunology consultant, where she provided technical expertise to support a biotechnology litigation case. Additionally, Olivia was an intern in the Office of Technology Management where she conducted prior art searches for patentability and determined commercial assessment of UCSF technologies.

Jeni Janci, PhD

Program Director
Catalyst

Jeni began her life science career in the start-up biotech industry before earning her Ph.D. at University of California, Berkeley in Mike Levine’s laboratory. Her thesis was focused on gene regulatory networks of heart development in the primitive chordate, Ciona intestinalis. Directly after her graduate career, she re-entered the life science industry, where at Entelos she provided Quantitative Systems Pharmacology (QSP) Modeling and Simulation services to assist Research & Development for international pharmaceutical companies and other life science applications. Through consulting projects, she applied large-scale, mechanistic systems models to make critical decisions in various stages of the drug discovery and development lifecycle. She was also one of the architects of the novel Hypertension, Renal Failure, and Heart Failure PhysioLab model. Jeni then expanded her work globally on the PhysioLab platforms via training programs and consulting services. 

Jeni is excited to help advance UCSF’s world-class research to positively impact people’s health and lives. As the newly hired Program Director, Jeni will manage the diagnostics, digital health and bio-tools projects for the Catalyst Program.

Nathaniel Prorok

Program Manager
Catalyst

Nathaniel Prorok brings a diverse and wide ranging skill set and experience to the Catalyst Program team. After undergraduate studies in Physical Therapy and Athletic Training at Loyola Marymount University, Nathaniel worked with the Jesuit Volunteer Corps - International in Tacna, Perú, with local communities to develop sustainable solutions to the problems they faced in health and education. Afterwards, Nathaniel earned a graduate degree in Healthcare Administration from Marquette University and worked with Children’s Hospital Wisconsin to develop a medical home for youth in foster care. Prior to joining the Catalyst Program, Nathaniel completed a fellowship at the University of Utah Health where he worked on various population health, wellness, and social determinants of health projects.

Roopa Ramamoorthi, PhD

Associate Director
Catalyst

Roopa Ramamoorthi brings a diverse scientific background in drug development, bacteriology, biotechnology, and engineering. Prior to joining UCSF, Roopa was Associate Director Partnering and Scientific Affairs at BIO Ventures for Global Health, where her focus was putting together collaborations between academic, non profit and pharmaceutical organizations to accelerate the development of drugs, vaccines and diagnostics for Neglected Tropical Diseases, TB and Malaria for the WIPO Re:Search Consortium. She worked for Bayer in California for more than five years as a scientist and senior scientist in development of antibody and other biological therapeutics and evaluating and bringing in platform technologies and has experience in science and technology consulting with Strategic Perspectives.

Roopa received her Ph.D. in biochemical engineering from the California Institute of Technology (Caltech) and conducted postdoctoral research at the University of Washington and at MIT. She is a registered patent agent and holds a Project Management Professional (PMP) certification. Roopa grew up in India where she received her B.S. in chemical engineering from the Indian Institute of Technology in Mumbai.

Daniel Abel, JD

Patent Prosecution and Business Manager
Office of Technology Management

Dan joined the OTM in March 2006, and is currently responsible for managing patent prosecution, agreement compliance, government reporting, case finances, and the operating budget. Dan earned both his B.A. (Phi Beta Kappa) and J.D. degrees from the University of Florida.

Kristin Agopian, PhD

Senior Licensing Officer
Office of Technology Management

Kristin has been managing intellectual property and commercialization for UCSF since 2008. Her portfolio of technologies includes therapeutics, diagnostics, and medical devices.  She works closely with UCSF faculty and staff to develop and commercialize their inventions, build large research collaboration and licensing partnerships, and spin out companies.  In addition, she negotiates and drafts IP agreements including licenses, options, inter-institutional agreements, CDAs and MTAs.

Kristin holds a Ph.D. in Virology from Harvard University and an A.B. in Molecular Biology from Princeton University. She has hands-on research experience in HIV pathogenesis, cell signaling, cell biology, mouse genetics and Drosophila development and speciation.  She also has experience in business strategy consulting in the biotechnology and pharmaceutical space and in science & technology policy at the National Academies.

Gonzalo Barrera-Hernandez, PhD

Senior Associate Director
Office of Technology Management

I joined UCSF in 2012, following 12 ½ years at the office of Innovation, Alliances & Services (IAS) (formerly known as the Office of Technology Transfer) at the UC Office of the President, where I was responsible for all IP management and technology licensing matters of a life-sciences portfolio of technologies from several UC campuses.  While at IAS I was also responsible for the first UC System Proof-of-Concept Fund, the UC System-Wide Technology Transfer Forum Program, the Technology Transfer Annual Report for the UC System, and for managing for the UC System the approval process for the acceptance of equity in licensing transactions.  Prior to joining UC, I worked in technology transfer for 2 years, on detail, at the NIH.

I received my Ph.D. in Biochemistry and Molecular Biology from the University of Calgary, Canada, where my research focused on gene regulation in Diabetes mellitus. My postdoctoral research at the NCI-NIH focused on the role of the thyroid hormone receptor in cell cycle regulation and on the mechanism controlling the switch from cell cycle regulation to differentiation.  I received a degree in Biological Sciences from the University of Buenos Aires, Argentina.

I am passionate about helping UCSF achieve its mission of advancing health worldwide through partnerships with industry, and by working closely with faculty to commercialize UCSF inventions.

Jon Brown, PhD

Licensing Associate
Office of Technology Management

Jon is a Licensing Associate at the Office of Technology Management where he supports the licensing efforts at UCSF. He received a Ph.D. in Chemistry from UCLA on the influence on cage environment on porous, catalytically active materials. After post-doctoral research and working as a Tech Transfer Fellow at Sandia National Laboratories, Jon worked as a Patent Agent at WSGR where he developed in-depth expertise in building intellectual property portfolios, counseled clients in due diligence matters, and collaborated with business, legal and scientific partners.

Darya Bubman, PhD

Licensing Officer, Engagement & Opportunity Development
Office of Technology Management

Darya is a Licensing Officer in the Engagement and Opportunity Development (EOD) team of the Office of Technology Management (OTM) at UCSF. In her role she evaluates novel UCSF inventions for market opportunity, identifies technologies that a start-up company could be built around, and works on developing business opportunities for such promising new ventures.

Darya joined OTM in November 2011. She earned a B.A. degree in Biochemistry from Cornell University in Ithaca, N.Y. and a Ph.D. in Pharmacology from the Weill Cornell Graduate School of Medical Sciences in New York City. She conducted her doctoral work in the laboratory of Dr. Ethel Cesarman, studying deregulation of cancer signaling pathways by the Kaposi’s sarcoma-associated herpesvirus (KSHV) in primary effusion lymphoma, a rare cancer that occurs in immunocompromised individuals. Following her graduate studies, Darya became an AAAS Science and Technology Policy Fellow and worked at the U.S. State Department on international issues related to biomedical IP, access to medicines and innovation. Prior to joining the OTM, she worked as a Technology Partnerships Manager for biomedical inventions at the NASA Ames Research Center located at Moffett Field, CA. Darya has a strong background in molecular biology, oncology and pharmacology.

Darya is passionate about working with UCSF faculty and staff to nurture new venture opportunities that have the potential to improve health on a global scale and change the world for the better.

Cole Bunn, MS

Licensing Associate, Engagement & Opportunity Development
Office of Technology Management

Cole joined the UCSF Office of Technology Management as a Licensing Associate in October of 2018 to aid in managing the University’s intellectual property disclosures and licensing efforts. Cole holds a B.S. in Molecular Biology and an M.S. in Biotechnology both from the University of Alabama at Birmingham (UAB). His research experience includes exploring the effects of epigenetic changes in human temporal lobe epilepsy, specifically methylation levels of the BDNF gene.

Cole has worked with a variety of early stage biotech/healthcare companies on various strategic projects. Prior to UCSF, he worked with a Boston-based firm that advised life science entrepreneurs on the market for their technology while executing campaigns to secure venture funding and strategic partnerships to advance their assets. Cole is passionate about translating UCSF’s scientific discoveries into business opportunities that will create life-changing treatments for patients.

Heather Carrico, MS

Business Analyst
Office of Technology Management

Heather joined the UCSF Office of Technology Management (OTM) in October 2013. She handles case and license agreement compliance, including analysis of license agreements for diligence and financial terms and interpretation, reporting and enforcement.

Prior to joining OTM, she was at Stanford University’s Office of Technology Management for eight years. Heather earned her MS degree from University of San Francisco and her BA from San Jose State University.

Danielle Casey Callaghan, BA

Patent Prosecution Analyst
Office of Technology Management

Danielle is primarily responsible for handling the intake of invention disclosures and compliance with federal and non-profit sponsor reporting obligations. Danielle also contributes to various projects for OTM, which she joined in May 2016.

Tanya Feldman, BA

Senior Patent Prosecution Analyst
Office of Technology Management

Tanya handles various aspects of patent prosecution, government reporting obligations, and monitoring annuities, as well as special projects to streamline the work of the Technology Management team and support the overall mission of the OTM. Prior to joining the office, Tanya spent more than a decade working with various non-profits and small businesses specializing in cultural exchange and education in an administrative and project support capacity.

David Fung, PhD

Assistant Director
Office of Technology Management

David manages intellectual property arising from research conducted at UCSF. He works with faculty and staff to evaluate new inventions and to develop appropriate IP strategies, with the goal of commercialization of the technology through licensing, whether to established companies or to new ventures.

David has more than ten years’ experience in academic technology transfer, first at Memorial Sloan-Kettering Cancer Center, and then at Yale University. Prior to that, he was with PricewaterhouseCoopers serving its biotech and tech clients. His Ph.D. is in biophysics from Harvard University, and he has master’s and bachelor’s degrees in physics from the University of Illinois, Urbana-Champaign and Stanford University respectively.

David is enthusiastic about working with faculty and other researchers to commercialize new technology for the benefit of the public.

Natalie Greco, PhD

Strategic Licensing and Patenting Manager
Office of Technology Management

Natalie's interest in disease prevention, therapeutics, and public health motivated her to obtain a PhD in Cellular and Molecular Pathology at the University of Wisconsin-Madison. These interests also drove her decision to shift into a career in technology transfer. Natalie takes pride in knowing that she is impacting public health by facilitating the development of biomedical technologies through licensing and intellectual property management.

As a Strategic Licensing and Patenting Manager in the Office of Technology Management, Natalie contributes to a variety of intellectual property, marketing, and technology licensing activities. With a focus on intellectual property arising from UCSF’s strategic partnerships, she handles the evaluation of inventions, prosecution of patents, marketing of technologies, and licensing of intellectual property and research tools. She also manages UCSF’s intellectual property obligations related to these strategic partnerships.

Before joining the Technology Management team at UCSF, Natalie worked at the National Institutes of Health (NIH) in the National Institute of Allergy and Infectious Diseases - Technology Transfer and Intellectual Property Office. At the NIH, Natalie drafted and negotiated a variety of agreements, including license agreements and collaboration agreements. She also worked closely with investigators to protect and commercialize their inventions, and fostered relationships with industry partners interested in further developing vaccine candidates and therapeutics discovered at the NIH.

Ellen Kats, PhD

Assistant Director
Office of Technology Management

As an Assistant Director of Licensing, Ellen is responsible for technology evaluation and management, commercializing technologies through licensing, as well as helping negotiate intellectual property terms for collaboration and sponsored research agreements with commercial partners. Ellen created and has been running the OTM's technology analyst internship program since 2012.

Ellen has been managing intellectual property on behalf of UCSF since February 2007, when she initially joined the Office of Technology Management. Over these years, Ellen has managed a large invention portfolio, completed a wide range of partnering deals, and played critical roles in the formations of several UCSF start-ups. Ellen holds a Ph.D. in Biomedical Science from UC San Diego, as well as a B.A. in Molecular and Cellular Biology from UC Berkeley. Her scientific background is strongest in molecular and cellular biology, cancer biology, and human and yeast genetics.

Ellen is passionate about aiding UCSF faculty and staff in realizing the fullest commercial potential in their inventions, and helping UCSF achieve its mission of advancing health worldwide through strategic partnerships leading to successes in clinical development and health sciences.

Heather Pittman, MBA

Strategic Projects Manager
Office of Technology Management

Heather is responsible for the negotiation of strategic partnering agreements for UCSF Innovation Ventures. She is focused on supporting those researchers, partners, and companies looking to engage in the UCSF research enterprise. Heather also advises on contractual intellectual property matters, analyzes and interprets research and intellectual property policies, and serves as a liaison on behalf of the Office of Technology Management.

Prior to arriving at UCSF in April 2018, Heather negotiated on behalf of UC Irvine, UC Berkeley and, most recently, UC Office of the President. Heather earned dual MBA-MA degrees from Claremont Graduate University, a member of the Claremont Colleges.

Priya Ramu, PhD

Licensing Officer, Engagement & Opportunity Development
Office of Technology Management

Priya Ramu is a Licensing Associate in the Office of Technology Management at UCSF. She helps manage intellectual property developed at UCSF by carrying out patentability assessments of inventions, coordinating patent prosecution and licensing of a variety of technologies to commercial partners.

She joined the office in 2016 and prior to that, contributed to Technology Transfer at Oregon Health & Science University by negotiating industry-sponsored research agreements, collaboration agreements and materials transfer agreements. Priya obtained her Ph.D. from the lab of Alexander Mankin at the University of Illinois at Chicago, where she investigated the molecular mechanism of ribosome stalling which is implicated in resistance to antibiotics. Prior to her Ph.D., Priya worked in the drug discovery group at Astra Zeneca, focusing on validating drug targets for Tuberculosis. Priya is excited about working at the intersection of academia and industry, where she can contribute towards translation of discoveries made in the lab to diagnostic, therapeutic or other commercial products to improve global health.

Gemma Rooney, PhD

Licensing Officer
Office of Technology Management

As a Licensing Officer, Gemma has over 5 years of experience in licensing and business development.  Gemma is responsible for evaluating and managing new technologies, determining the commercial and patenting strategy, engaging with faculty, building new relationships with industry partners and early stage investors, and negotiating license agreements, as well as the intellectual property terms in sponsored research agreements. Gemma and her colleague, Cathy Smith, manage the licensing internship program, which provides early career scientists a unique opportunity to learn about university technology commercialization and intellectual property management.

Gemma holds a Ph.D. in Neuroscience and Stem Cell Biology from the National University of Ireland, Galway, and a B.Sc. in Neuroscience from University College Cork, Ireland. She received postdoctoral training from the University of California, San Francisco and the Mayo Clinic College of Medicine. Her research focused on neurological applications of stem cell therapies.

Gemma is passionate about guiding UCSF investigators in realizing the fullest commercial potential of their innovations.  She loves working at the interface between academia and industry, establishing partnerships that have the potential to benefit patients worldwide.

Shikha Sharma, PhD

Senior Licensing Officer, Engagement & Opportunity Development
Office of Technology Management

I joined the Office of Technology Management in January 2013. I am a zealous business development professional, with a passion for science and immense respect for innovators. I am privileged to work closely with the UCSF community of students, scientists, clinicians. I manage a diverse and exciting intellectual property portfolio and catalyze the transfer of UCSF scientific developments to the public through licensing and partnerships.

I am responsible for managing a portfolio of intellectual property developed by UCSF researchers comprising of therapeutic, device, software and dHealth technologies. My activities comprise evaluating invention disclosures from the campus laboratories; conducting technology assessments from a commercial perspective; formulating and implementing licensing and intellectual property management strategies; marketing the technology to prospective licensees; coordinating the filing and prosecution of patent applications; negotiating and writing contractual agreements and licenses.

I hold a BS in Life Sciences (with Honors), M.S in Molecular Genetics (with Distinction) and Ph.D. in Cardiovascular Sciences (2011). I did my doctoral work on Angiopoietin ligands at the University of Leicester, UK, where I studied the molecular basis of Angiopoietin-Tie binding interaction using a combination of rational design and directed evolution. I like reading about latest scientific innovations and enjoy the uniqueness and challenges in the field of intellectual property and technology transfer.

Catherine Smith, PhD

Licensing Officer
Office of Technology Management

In her role as a Licensing Associate for UCSF’s Innovation Ventures, Cathy is responsible for managing the University’s diverse intellectual property disclosures and assisting in licensing transactions.  Cathy joined the office in early 2016 and is enthusiastic about aiding faculty and staff in translating their scientific discoveries for the public benefit through commercial partnerships.

Cathy did her PhD at Columbia University and a post-doctoral fellowship at Ludwig Cancer Research– both focused on understanding the DNA damage response through biochemical, genetic, and molecular biology approaches.

Kathleen Wilson-Edell, PhD

Licensing Officer
Office of Technology Management

Kathy joined the UCSF Office of Technology Management (OTM) in March of 2014. She works with UCSF faculty members to protect intellectual property arising from their research and negotiates licenses to these technologies with both startups and established companies.

Prior to joining OTM full-time, Kathy was a part-time Technology Analyst with UCSF OTM while completing her postdoctoral training at the Buck Institute for Research on Aging in Dr. Christopher Benz’s laboratory. Her postdoctoral research focused on the role of ribosomal proteins in breast cancer. She received her Ph.D. in Genetics from Yale University in Dr. David Stern’s laboratory, studying regulation of gene expression and cytoskeleton rearrangement by BRCA1-related proteins. Kathy’s A.B. is from Cornell University, where she was a Presidential Research Scholar.

Kathy is passionate about helping UCSF investigators move their discoveries from the laboratory to the public domain.

Laurel Skurko

Program Manager
Entrepreneurship Center

Proud to be a member of the Entrepreneurship Center at UCSF Innovation Ventures. Marketing strategy and digital media expert with 10+ years executing communications strategies in the life sciences, technology and education sectors. A Harvard MBA and Stanford Human Biology undergraduate, it is my privlege to support UCSF inventors through the lens of entrepreneurship and marketing.

Michael Blum, MD

Director
Center for Digital Health Innovation

Dr. Michael Blum is the Associate Vice Chancellor for Informatics and the Chief Digital Transformation Officer at the University of California, San Francisco. Dr. Blum is responsible for UCSF’s strategic design and implementation of informatics and digital health capabilities in support of clinical care delivery and discovery. He is also a Professor of Medicine in Cardiology, specializing in preventative cardiology and the care of patients with congestive heart failure, valvular heart disease, and general cardiology. Dr. Blum is passionate about wellness and the prevention of heart disease through a heart-healthy lifestyle that includes diet, exercise and stress reduction, as well as early detection of heart disease and aggressive medical intervention to reduce its impact. His clinical and informatics activities intersect as he drives the digital transformation of care delivery.

Dr. Blum earned his medical degree from New York University School of Medicine. He completed an internship and residency in internal medicine, followed by a fellowship in cardiovascular medicine at Yale University School of Medicine. He is a fellow of the American College of Cardiology and a member of numerous professional organizations, including the American College of Cardiology, and Association of Medical Directors of Information Systems. He is the recipient of numerous honors and awards, such as the AMDIS Award for Excellence and Achievement in Advancement of Clinical Information Systems. Dr. Blum is a Clinical Professor of Medicine in the Division of Cardiology at UCSF.

Prior to his medical career, Dr. Blum was trained as an engineer and applies his expertise in technology to health care as UCSF’s Chief Digital Transformation Officer and the Executive Director of the UCSF Center for Digital Health Innovation (CDHI). Previously, he was a leader of the successful enterprise deployment of Epic’s electronic health record and the development of a large-scale enterprise networked data warehouse that will supports the campus’s clinical, research, and education missions and expands data and information sharing and aggregation across the University of California system and nationally.

Dr. Blum has a special interest in the application of digital technologies and clinical decision support to improve clinical care. As the Executive Director of the CDHI, he leads UCSF’s early stage validation and incubation of digital health technologies to improve wellness preservation and disease management. After successful validation of these technologies, CDHI collaborates with industry partners to commercialize and distribute the solutions. Dr. Blum led the formation of the UCSF-Samsung Digital Health Innovation Laboratory, the UCSF-Cisco collaboration to develop the Connected Health Interoperability Platform, and the UCSF-GE collaboration on artificial intelligence and deep learning in healthcare.

Rachael Callcut, MD

Director of Data Science & Advanced Analytics
Center for Digital Health Innovation

Dr. Callcut is General Surgeon and Associate Professor of Surgery at San Francisco General Hospital and Trauma Hospital. She leads a NIH and DOD funded team of researchers focused on integration of biomedical big data and surgical data science into critical care for improved clinical decision support.

Mary Elizabeth Chalk

Business Development
Center for Digital Health Innovation

Mary Beth is responsible for business development, including the recent transaction with GE. She has 25 years of broad healthcare expertise in conceiving and completing deals in digital health, biopharma, behavioral health, disease management, wellness, health systems, pharmacy benefit management, and health plans. Prior to UCSF, she was a co-founder of a venture capital backed digital health coaching solution built from IP validated at Partners Healthcare. Mary Beth holds a BBA in marketing and a BFA in commercial design.

Ed Martin

Director, Technology
Center for Digital Health Innovation

Ed is a technologist with 20+ years of experience in software engineering with the last 5 years at UCSF focused on cloud-computing application solutions.  He has a B.S. in Computer Science from UC Davis and a M.Sc. in Healthcare Information Technology from Boston University.

Aaron Neinstein, MD

Assistant Clinical Professor
Center for Digital Health Innovation

Aaron Neinstein, MD is Assistant Professor of Medicine at UCSF and Director of Clinical Informatics at the UCSF Center for Digital Health Innovation. He is board-certified in Internal Medicine, Endocrinology, and Clinical Informatics, and maintains an active clinical practice in Endocrinology. His expertise in the development and use of novel diabetes technologies spans publishing peer-reviewed articles, consulting and advising companies, speaking at conferences and educational events, and blogging for Medscape. Dr. Neinstein believes in empowering patients and physicians to access, share, understand, and use health information in day-to-day care, including outside of traditional healthcare settings. He has devoted his informatics career to advancing health policy and creating tools that facilitate connected, collaborative care as well as ecosystems that enable integration of innovative software into care delivery workflows. He helped lead UCSF's Epic EHR implementation and optimization and was on the founding team of Tidepool, a non-profit that creates open-source software to empower people with diabetes. At the UCSF CDHI, he leads a multi-disciplinary team focused on digital transformation of care delivery at UCSF, development and commercialization of novel technologies, and enablement of the national digital health ecosystem. He majored in American Studies at Northwestern University, graduated Alpha Omega Alpha from the Keck School of Medicine of USC, and did his Internal Medicine residency and Endocrinology fellowship at UCSF. He was selected as one of the inaugural inductees as a Fellow of the American Medical Informatics Association (FAMIA).

Rhona Snyman

Chief Strategy Officer
Center for Digital Health Innovation

Rhona is the Chief Strategy Officer for UCSF’s Center for Digital Health Innovation, responsible for developing, communicating, executing, and sustaining CDHI’s strategic initiatives. Prior to joining CDHI, Rhona was responsible for overseeing product development and business strategy for UCSF School of Medicine IT, which included planning the early-stage adoption of innovation programs such as Telemedicine and SalesForce. Rhona earned an honors B.S. in Computer Science at UCC, Ireland.

Elizabeth Gress, MPA

Dir. Strategy & Operations
Surgical Innovations Team

Elizabeth manages the Surgical Innovations program, playing a key role in goal-setting, strategic planning, and outreach. Working closely with faculty leadership, Liz oversees Surgical Innovations’ accelerator and seed funding program, organizes project teams, and coordinates with stakeholders across campus.

Hanmin Lee, MD

Professor
Surgical Innovations Team

Dr. Lee is a pediatric surgeon with research interests in the integration of emerging devices and technologies in medicine. As Clinical Director of Surgical Innovations, Dr. Lee is passionate about collaborating with multidisciplinary experts to solve clinical needs.

Shuvo Roy, PhD

Professor
Surgical Innovations Team

Shuvo Roy, PhD, is a bioengineer focusing on the development of medical devices to address unmet clinical needs through strong collaboration and a multidisciplinary approach.

Dr. Roy is a professor at the University of California, San Francisco in the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the UCSF Schools of Pharmacy and Medicine, and is a faculty affiliate of the California Institute for Quantitative Biosciences (QB3). He is the director of the Biodesign Laboratory located on the Mission Bay campus. In addition, he serves as the Technical Director of The Kidney Project and is a founding member of the UCSF Pediatric Device Consortium. He has developed and currently teaches a course on medical devices, diagnostics, and therapeutics and regularly lectures on the medical device design process to UCSF graduate students and to national and international academic and industry audiences. He is the author of more than 100 publications and co-author of three book chapters, and holds multiple patents for device developments.

Before joining UCSF in 2008, Roy co-directed the BioMEMS Laboratory in the Department of Biomedical Engineering at Cleveland Clinic in Cleveland, Ohio, focusing on clinical applications of MEMS. In 1992 he earned a BS degree, magna cum laude, for triple majors in physics, mathematics, and computer science, from Mount Union College in Alliance, Ohio. In 1995, he earned an MS in electrical engineering and applied physics and, in 2001, he earned a PhD in electrical engineering and computer science, both from Case Western Reserve University in Cleveland, Ohio.

He is the recipient of a Top 40 under 40 award by Crain’s Cleveland Business in 1999 and the Clinical Translation Award at the 2nd Annual BioMEMS and Biomedical Nanotechnology World 2001 meeting. In 2003, Dr. Roy was selected as a recipient of the TR100, which features the world’s 100 Top Young Innovators as selected by Technology Review, the Massachusetts Institute of Technology’s Magazine of Innovation. In 2004, he was presented with a NASA Group Achievement Award for his work on harsh environment MEMS. In 2005, Dr. Roy was named as a Who’s Who in Biotechnology by Crain’s Cleveland Business. In 2005 and 2007, he was recognized as a Cleveland Clinic Innovator. In 2009, he was nominated for the Biotechnology Industry Organization's Biotech Humanitarian Award, which is given in recognition of an individual who has used biotechnology to unlock its potential to improve the earth. In 2012, he was presented the Rising Star Award by BayBio Pantheon, and in that same year, he received the Innovation Pathway 2.0 Award from the Food and Drug Administration (FDA). Most recently, he was recognized as a Fellow by the Applied Innovation Institute in 2013.

Jessica Chao, MBA, PharmD

Director
Clinical Innovation Center

Jessica overseas day-to-day operations and leads CIC partnerships with industry and academia. Previously, she has led product design in various San Francisco startups as well as co-founded Healtho, a consumer health information company. She is also the co-founder of one of the largest health meetups in Seattle, the Seattle Health Innovators.

Jessica received her MBA from the Johns Hopkins Carey Business School in 2012 while she concurrently completed her Residency in Health System Pharmacy Administration at Johns Hopkins Medicine. She also holds a Doctorate in Pharmacy and BS in Biochemistry from the University of Washington. While in college, she attended the UW Academy, an early entrance program for young scholars to attend university at an early age.

Ralph Gonzales, MD, MSPH

Chief Innovation Officer
Clinical Innovation Center

Dr. Ralph Gonzales is Associate Dean for Clinical Innovation and Chief Innovation Officer for UCSF Health. His research has played a significant role in national and global efforts to combat antimicrobial resistance by improving antibiotic prescribing practices - the body of which provides a successful roadmap for translating evidence into practice, policy and public health. Dr Gonzales’ research is multidisciplinary, patient-centered, and informed by relevant stakeholders and policy makers such as the CDC, NCQA, professional societies and community clinicians and patients. It represents the full spectrum of translational research - from practice guideline development, to implementation of innovative health care interventions, to conducting larger community-based trials to examine the comparative effectiveness of different health care interventions.
In addition, Dr. Gonzales is currently leading several project teams in designing, implementing and evaluating new ways to improve primary care-specialty care communication and care coordination, focusing on strategies that achieve the triple aim of improving quality, outcomes and decreasing costs. One includes the use of eReferrals and eConsults to streamline the referral and coordination process; another project is evaluating new team-based strategies to reduce unnecessary follow-up visits in specialty care.

Julianne Bautista, MSN, RN

Investment Associate
Innovation Ventures Philanthropy Fund (InVent Fund)

Julianne was born in Silicon Valley and is a Northern California native. She completed her Bachelors of Science in Nursing at New York University and brings four years of clinical inpatient bedside experience. After working at New York-Presbyterian/Weill Cornell Medical Center, she relocated to the Hospital of University of Pennsylvania where she cared for critically ill patients on an Advanced Medicine Acute Care Unit. As a staunch advocate for patient-centered care and with a desire to create innovative, strategic and lasting solutions to healthcare delivery, Julianne pursued a Masters of Science in Nursing and Healthcare Administration at University of Pennsylvania with a focus in Healthcare Management from the Wharton Business School. While at Penn, she was elected student body President where she led a variety of initiatives and served as a project lead at Penn Medicine. After graduate school, Julianne was awarded a UCSF Health Administrative Fellowship - a highly competitive two-year rotational program that recognizes early professionals who can develop their business knowledge, analytical skills and leadership potential within a dynamic and unique health system. She has been mentored by UCSF senior leaders and worked side-by-side with hospital executives in financial, operational, innovative and strategic growth arenas.

During the first year of the fellowship, Julianne spent her first three months working solely with the Chief Financial Officer and Chief of Faculty Physician Practices to build a multi-year strategic plan to address payor mix and fiscal sustainability (recommendations reduced net losses by $122M over three fiscal years). She also co-developed phase 1 of the Canopy Health mobile app and led an interoperability analysis to implement referral platform solutions for our Accountable Care Network. Julianne was also part of the UCSF Entrepreneurship Center where she joined a team building a startup in next generation cellular therapy in pharmaceutical CAR T-cell treatment. In her second year, Julianne worked in the Department of Finance focusing on strategic planning at UCSF Benioff Children's Hospitals as well as UCSF Innovation Ventures. Most notably, she led the business case creation and presentation to secure >$1M investment for UCSF’s Metagenomic Next-Gen Sequencing technology.

Julianne reports directly to the Vice Chancellor of Business Development, Innovation & Partnerships and assists in investment analyses for UCSF’s most promising technologies and discoveries.